Xcell Therapeutics Inc. (KOSDAQ:373110)
1,609.00
+10.00 (0.63%)
At close: Dec 5, 2025
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 17.60 billion as of December 5, 2025. Its market cap has decreased by -70.20% in one year.
Market Cap
17.60B
Enterprise Value
22.75B
Revenue
1.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,609.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 17.60B, a decrease of -80.49%. That is a compound annual growth rate of -69.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 17.60B | -60.35% |
| Dec 30, 2024 | 44.38B | -50.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.11T |
| ALTEOGEN | 27.92T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 6,906.05B |
| Peptron | 6,668.76B |